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Introduction
The high doses of verapamil (480 to 960 mg per day)
needed in cluster headache prevention are most likely due
to a need for the drug to exert an effect in the CNS. Vera-
pamil is cell permeable due to its lipophilic nature, but is
also, at the same time, a substrate for the BBB efflux
pump P-glycoprotein (P-gp). If the efflux of verapamil
could be selectively inhibited the blood concentration of
verapamil needed for an CNS effect could probably be
decreased.
In an in vitro study using a P388/dx cell line, “telmisar-
tan was identified as one of the most potent inhibitors of
P-gp currently known” [Biopharm. Drug Disp. 2010; 31:
150-161.]. We therefore investigated whether telmisartan
could modulate the transport of verapamil in an in vitro
model of the BBB.
Methods and results
In bi-directional transport experiments (n=6), telmisartan
(2.4 µM) increased both uptake and permeability of vera-
pamil in MDCK-II MDR1 cells cultured on permeable
supports. Telmisartan also reduced the ratio between
brain to blood and blood to brain transport; indicating a
telmisartan-mediated modulation of verapamil efflux.
Telmisartan did not affect efflux transport of digoxin.
Discussion
The main result of this in vitro of the transport across
the BBB was the indication of a telmisartan-mediated
inhibition of verapamil efflux transport. The lack of effect
of telmisartan on efflux transport of digoxin might indi-
cate that the observed effects on verapamil efflux are not
related to inhibition of P-gp or that telmisartan does not
block the digoxin-binding site at P-gp.
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